Browsing by Author Wong, RLC

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 18 to 37 of 68 < previous   next >
TitleAuthor(s)Issue DateViews
 
Elevated fibroblast growth factor-21 is associated with increased carotid intima media thickness
Proceeding/Conference:Annual Meeting & Expo of the Endocrine Society, ENDO 2012
2012
33
2006
124
 
Ethnicity is a factor to be considered before dose planning in ovarian cancer patients to be treated with Topotecan
Proceeding/Conference:Annual Congress of Japan Society of Obstetrics and Gynaecology
2005
108
 
2001
123
 
1996
77
 
Germ cell tumour
Proceeding/Conference:Asia-Pacific Cancer Congress
1995
102
 
Gestational Trophoblastic Disease
Book:In: F. Lawton, M. Friedlander and G. Thomas (eds.), Essentials of Gynaecologic Cancer
1997
109
 
2001
101
 
An idiosyncratic drug reaction to methotrexate?
Proceeding/Conference:World Congress on Gestational Trophoblastic Diseases
1994
83
 
2017
126
2003
112
 
2004
149
 
1994
207
 
Long term survival analysis of high dose versus low dose cis-platinum combined with cyclophosphamide in advanced ovarian cancer
Proceeding/Conference:Biennial Meeting of the International Gynecologic Cancer Society
1999
93
 
Loop Electrosurgical Excision Procedure: A Review of Our Recent Experience
Journal:Chinese Journal of Obstetrics and Gynecology
1997
149
 
Management of ovarian germ cell tumour
Book:In: D. Gersherson and R.F. Ozols (eds.), Controveries in the management of ovarian cancer
1997
118
 
Mitochondrial DNA Mutations In Human Ovarian Cancer
Proceeding/Conference:Proceedings of the American Association for Cancer Research
2001
73
 
Mitomycin pleurodesis in advanced gynecologic cancer
Proceeding/Conference:Biennial Meeting of the International Gynecologic Cancer Society, IGCS 1995
1995
92
 
Monitoring of serum squamous cell carcinoma antigen levels in invasive cervical cancer: Is it cost-effective?
Proceeding/Conference:Asian & Oceanic Congress of Obstetrics & Gynaecology, AOCOG 2002
2002
83
 
A new paradigm for the rational selection of salvage therapy in recurrent epithelial ovarian cancer: Shouldn't it be directed by in vitro assay?
Proceeding/Conference:The 14th Asia Pacific Cancer Conference - 4th Hong Kong International Cancer Congress
1997
95